Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1998
DOI: 10.1038/sj.bjp.0702001
|View full text |Cite
|
Sign up to set email alerts
|

2′,3′‐O‐(2,4,6‐ trinitrophenyl) adenosine 5′‐triphosphate (TNP‐ATP)–a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels

Abstract: 1 P2X receptor activation by a,b-meATP evoked inward currents in acutely dissociated rat mesenteric artery smooth muscle cells and contractions of whole artery rings. 2 The selective P2X 1 and P2X 3 receptor antagonist TNP-ATP inhibited P2X receptor mediated inward currents in response to 3 mM a,b-meATP (an *EC 90 concentration) with an IC 50 of *2 nM. This provides further evidence that the P2X receptor underlying membrane depolarisation associated with P2X receptor activation can be accounted for by the expr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
71
1

Year Published

2000
2000
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 80 publications
(72 citation statements)
references
References 14 publications
0
71
1
Order By: Relevance
“…Rapidly desensitizing current responses to both ATP and the selective P2X 1,3 agonist a,b-meATP (Ralevic and Burnstock 1998) were observed as a characteristic feature of homomeric P2X 3 receptors (Lewis et al 1995). Furthermore, the P2X 1,3 receptor antagonist TNP-ATP (Lewis et al 1998) and the P2X 1,2,3 preferential antagonist PPADS (Lambrecht 2000) markedly inhibited the effect of a,b-meATP. A few experiments were aimed at clarifying why the concentration-response curve for a,b-meATP had a higher maximum than that for ATP itself.…”
Section: Discussionmentioning
confidence: 99%
“…Rapidly desensitizing current responses to both ATP and the selective P2X 1,3 agonist a,b-meATP (Ralevic and Burnstock 1998) were observed as a characteristic feature of homomeric P2X 3 receptors (Lewis et al 1995). Furthermore, the P2X 1,3 receptor antagonist TNP-ATP (Lewis et al 1998) and the P2X 1,2,3 preferential antagonist PPADS (Lambrecht 2000) markedly inhibited the effect of a,b-meATP. A few experiments were aimed at clarifying why the concentration-response curve for a,b-meATP had a higher maximum than that for ATP itself.…”
Section: Discussionmentioning
confidence: 99%
“…6b, d, f, h). The selective P2X receptor antagonist TNP-ATP [42,43] did not exert any significant effect on cardiac gene expression, indicating that P2X receptors may not be involved in stem cell differentiation toward cardiomyocytes (data not shown).…”
Section: Inhibition Of Cardiac-specific Gene Expression Upon Pharmacomentioning
confidence: 95%
“…Analgesic pharmacology and drug-like properties of P2X receptor antagonists P2X3 receptors Table 3 onists that have been studied in a wide variety of animal pain models [8,[26][27][28][29][30][31]. The utility of these antagonists for delineating mechanistically specific contributions of individual P2X receptors to pain is limited by their nonselective pharmacology and generally weak potency [10].…”
Section: Gabapentinmentioning
confidence: 99%
“…2′(3′)-O-(2,4,6-Trinitrophenyl) ATP (TNP-ATP; compound 1) is a nonselective but highly potent antagonist of P2X1 receptors and P2X3 receptors [9,29]. The ability to use this antagonist for preclinical pain studies in rodents is limited by its poor metabolic stability in plasma [30].…”
Section: Gabapentinmentioning
confidence: 99%